Position in MNKD
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$135,075
-$1,218,246 QoQ
Shares Held
55,133
-76.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in MNKD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $135,075 | 55,133 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,353,321 | 238,681 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $473,162 | 94,068 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $255,798 | 39,782 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $412,762 | 65,622 | Shares | Sole | 2024-11-15 | |
| 2024-03-31 | $93,607 | 20,664 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $161,094 | 39,006 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $72,743 | 17,873 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $139,565 | 26,483 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $63,280 | 16,609 | Shares | Sole | 2022-08-08 | |
| No filing history on record for this holder in this stock. | ||||||